Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is a paper indexed in PICO Portal from OpenAlex.
How many citations does Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways have?
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has 54 citations in the OpenAlex counts PICO Portal stores.
When was Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways published?
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has 2022 year in the PICO Portal index.
What is the open-access status of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has gold oa status in the PICO Portal index.
What is the DOI of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?
The DOI for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.
What is the PMID of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?
The PMID for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.
What is the OpenAlex record for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?
The OpenAlex for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.